References
- Litovitz TL, Schmitz BF, Bailey KM. 1989 annual report of the American Association of Poison Control Centers National Data Collection System. Am J Emerg Med 1990: 8(5): 394–442
- Vukmir RB, Paris PM, Yealy DM. Glucagon: prehospital therapy for hypoglycemia. Ann Emerg Med 1991: 20(4): 375–9
- Teba L, Schiebel F, Dedhia HV, et al. Beneficial effect of norepinephrine in the treatment of circulatory shock caused by tricyclic antidepressant overdose. Am J Emerg Med 1988: 6(6): 566–8
- Arnold FJ Jr, Hodges JB Jr, Barta RA Jr, et al. Evaluation of the efficacy of lavage and induced emesis in treatment of salicylate poisoning. Pediatrics 1959: 23(Feb): 286–301
- Boxer L, Anderson FP, Rowe DS. Comparison of ipecac-induced emesis with gastric lavage in the treatment of acute salicylate ingestion. J Pediatr 1969: 74(5): 800–3
- Abdallah AH, Tye A. A comparison of the efficacy of emetic drugs and stomach lavage. Am J Dis Child 1967: 113(5): 571–5
- Krenzelok EP. Ipecac vs lavage: pros and cons. Crit Decisions Emerg Med 1988: 3: 1–8
- Auerbach PS, Osterloh J, Braun O, et al. Efficacy of gastric emptying: gastric lavage versus emesis induced with ipecac. Ann Emerg Med 1986: 15(6): 692–8
- Tandberg D, Diven BG, McLeod JW. Ipecac-induced emesis versus gastric lavage: a controlled study in normal adults. Am J Emerg Med 1986: 4(3): 205–9
- Lipscomb JW, Burda AM, Holbrook MG. Response in children to 15-mL or 30-mL doses of ipecac syrup. Clin Pharm 1986: 5(3): 234–5
- Grbcich PA, Lacouture PG, Lovejoy FH Jr. Effect of fluid volume on ipecac-induced emesis. J Pediatr 1987: 110(6): 970–2
- Amitai Y, Mitchell AA McGuigan MA, et al. Ipecac-induced emesis and reduction of plasma concentrations of drugs following accidental overdose in children. Pediatrics 1987: 80(3): 364–7
- Krenzelok EP, Dean BS. Effectiveness of 15-mL versus 30-mL doses of syrup of ipecac in children. Clin Pharm 1987: 6(9): 715–7
- Kulig K, Bar-Or D, Cantrill SV et al. Management of acutely poisoned patients without gastric emptying. Ann Emerg Med 1985: 14(6): 562–7
- Tenenbein M, Cohen S, Sitar DS. Efficacy of ipecac-induced emesis, orogastric lavage, and activated charcoal for acute drug overdose. Ann Emerg Med 1987: 16(8): 838–41
- Albertson TE, Derlet RW, Foulke GE, et al. Superiority of activated charcoal alone compared with ipecac and activated charcoal in the treatment of acute toxic ingestions. Ann Emerg Med 1989: 18(1): 56–9
- Neuvonen PJ, Olkkola KT. Oral activated charcoal in the treatment of intoxications: role of single and repeated doses. Med Toxicol Adverse Drug Exp 1988: 3(1): 33–58
- Krenzelok EP, Lush RM. Container residue after the administration of aqueous activated charcoal products. Am J Emerg Med 1991: 9(2): 144–6
- Krenzelok EP, Keller R, Stewart RD. Gastrointestinal transit times of cathartics combined with charcoal. Ann Emerg Med 1985: 14(12): 1152–5
- Filippone GA Fish SS, Lacouture PG. et al. Reversible adsorption (desorption) of aspirin from activated charcoal. Arch Intern Med 1987: 147: 1390–2
- Keller RE, Schwab RA, Krenzelok EP. Contribution of sorbitol combined with activated charcoal in prevention of salicylate absorption. Ann Emerg Med 1990: 19(6): 654–6
- Farley TA. Severe hypernatremic dehydration after use of an activated charcoal-sorbitol suspension. J Pediatr 1986: 109(4): 719–22